Manhattan Psychiatric Center
New York, 10035, United States
NCT Number: NCT00661869
Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and metabolic syndrome issues, Manhattan Psychiatric Center (MPC) has implemented the Solutions for Wellness and Team Solutions Program. This program is designed to create a supportive, educational and monitoring environment to stabilize both the psychiatric and medical conditions and to prepare patients for independent management of their psychiatric and physical health condition in the community.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
New York, 10035, United States
The present program is divided into five detailed segments with three progressive levels, that provide a manualized lesson-by-lesson curriculum for implementation on the treatment mall.
The program comprised of detailed instructor and patient manuals, specific curriculums and pre- and post-tests to determine acquisition of the learned materials. All modules are imbedded in weekly small group sessions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
36 weeks of educational and supportive interventions
Time frame: 36 weeks
Time frame: 36 weeks
Time frame: 36 weeks
Manhattan Psychiatric Center
Other
Acronym: Wellness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04298450
Affective Disorders, Psychotic, Bipolar Disorder
Toronto, Ontario, Canada
View Trial DetailsNCT05030272
Bipolar Disorder, Bipolar and Related Disorders
Buffalo, New York, United States
View Trial DetailsNCT05380583
Alcohol, Bipolar Disorder
Belmont, Massachusetts, United States
View Trial DetailsNCT05859698
Bipolar Disorder, Bipolar and Related Disorders
Bryant, Arkansas, United States
View Trial Details